Orphazyme A/S
ORPHA
Rank in Stocks
#3640
Orphazyme A/S currently conducts no significant business operations.... Orphazyme A/S currently conducts no significant business operations. Previously, the firm specialized in developing therapeutic solutions for rare neurodegenerative conditions. Established in 2009, its corporate headquarters are situated in Copenhagen, Denmark.
Share Price
$133.39
Last synced: 2024-11-19
Market Cap
$4.66B
Change (1 day)
-0.13%
Change (1 year)
0.00%
Country
DK
Trade Orphazyme A/S (ORPHA)
Category
Healthcare
Revenue for Orphazyme A/S (ORPHA)
Revenue in Oct 2026 TTM: 0
According to Orphazyme A/S latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Orphazyme A/S from 2026 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| - | - |
CH
|
